FIELD: medicine.
SUBSTANCE: claimed is method of formation of radiological risk group, which includes selection of people, who have accumulated considerable doze of occupational radiation, and estimation of frequency of genetic mutations at locus of T-cell receptor on the basis of analysis of peripheral blood samples. Criterion of threshold value of accumulated dose of radiation ≥ 55 mSv is introduced, after which frequency of mutant cells of tested people is determined. If value is ≥ 6.3×10-4, group of risk of development of oncologic disease, caused by radiation factor, is formed.
EFFECT: objective selection of employees, subjected to occupational radiation at enterprise, requiring measurement of frequency of genetic mutations and possibility of formation of group of risk of oncologic disease development among them.
3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF DEVELOPING MALIGNANT GROWTHS IN RADIATION EXPOSURE | 2012 |
|
RU2521393C2 |
METHOD FOR DETECTING THE FREQUENCY OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES BEING MUTANT BY T-CELL RECEPTOR | 2006 |
|
RU2316766C1 |
METHOD FOR DETERMINING RADIATION-INDUCED ATHEROSCLEROTIC VASCULAR DISEASE IN WORKERS EMPLOYED IN HAZARDOUS WORKING CONDITIONS AT RADIATION HAZARDOUS ENTERPRISE | 2023 |
|
RU2816338C1 |
METHOD FOR DETECTING RADIATION OR RADIOMIMETIC CHEMICALS ACTION EARLIER EXERTED UPON MAMMALS | 1996 |
|
RU2174686C2 |
METHOD FOR PREDICTION OF DEVELOPING OCCUPATIONAL MALIGNANT SKIN GROWTHS IN FIBREGLASS PRODUCTION WORKERS | 2011 |
|
RU2454668C1 |
STATISTICAL ESTIMATION METHOD OF A MULTIFACTOR TREND OF CONDITIONAL PROBABILITY OF THE OCCURRENCE OF A STUDIED UNDESIRED EVENT IN COHORT STUDY | 2016 |
|
RU2654125C1 |
METHOD FOR MOLECULAR-GENETIC PREDICTION OF THE RISK OF CHRONIC DUST BRONCHITIS IN COAL MINING WORKERS | 2021 |
|
RU2767916C1 |
METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY OF HUMAN GENOME TO RADON EXPOSURE | 2009 |
|
RU2415427C1 |
CANCER TUMOUR RESPONSE DETERMINANTS FOR IMMUNOTHERAPY | 2014 |
|
RU2707530C2 |
PROGNOSIS METHOD FOR DISEASE PROGRESSION IN PATIENTS WITH GASTROINTESTINAL CANCER AFTER TREATMENT | 2021 |
|
RU2758079C2 |
Authors
Dates
2013-09-10—Published
2012-07-05—Filed